IgG Fc binding protein (FCGBP) inhibits the development of laryngeal squamous cell carcinoma and cisplatin resistance through the PIGR/JAK2/STAT3 pathway. This evidence concerns the gene STAT3 and laryngeal squamous cell carcinoma.